Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Immune cells from tumors could offer new hope for kids with relapsed cancers

NCT ID NCT06566092

First seen Apr 25, 2026 · Last updated Apr 30, 2026 · Updated 2 times

Summary

This study tests whether immune cells taken from a patient's own tumor can be safely given back to fight cancer. It includes children, teenagers, and young adults with solid tumors that have come back or stopped responding to standard treatments. The goal is to check for side effects and see if the treatment shrinks tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Children's Hospital of Colorado

    Aurora, Colorado, 80045, United States

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida, 33701, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, 14203, United States

  • Rutgers Cancer Institute

    New Brunswick, New Jersey, 08901, United States

Conditions

Explore the condition pages connected to this study.